The Genius Life 399: How Big Food and Big Pharma Work Together to Profit Off Chronic Disease | Calley Means
16 snips
May 27, 2024 
Former consultant Calley Means discusses the collaboration between Big Food and Big Pharma to profit off chronic diseases. Topics include metabolic health, the influence of industries on medical recommendations, benefits of high-quality collagen, over-reliance on medications, revolutionizing healthcare with personalized medicine, and fighting against unhealthy food choices.
AI Snips
Chapters
Transcript
Episode notes
Chronic Disease Is A Siloed Systemic Failure
- The medical system siloing treats chronic diseases separately rather than as interconnected metabolic dysfunction.
- That fragmentation creates incentives for prolonged treatment instead of addressing root causes.
Surgeon's Awakening To Metabolic Links
- Casey noticed her sinus surgery patients often had multiple comorbidities like diabetes and depression.
- She was reprimanded for asking whether inflammation related to diet and metabolic health.
Funding Shapes Medical Standards
- Pharma funds medical schools, research, regulators and media, shaping standards and public opinion.
- Those funding flows incentivize treating symptoms with drugs rather than preventing metabolic disease.